Page 1 of Clinical Trials for EGFR-tyrosine kinase inhibitor, 90 Total Matches
- 1CompletedLast Updated: December 7, 2011Condition(s): Pancreatic Cancer
- 2CompletedLast Updated: May 29, 2009Condition(s): Metastatic Colorectal Cancer; Non-Small-Cell Lung Carcinoma
- 3Active, not recruitingLast Updated: April 20, 2011Condition(s): Solid Tumor
- 4Active, not recruitingLast Updated: December 7, 2011Condition(s): EGFR Inhibitor-associated Rash
- 5RecruitingLast Updated: June 3, 2010Condition(s): Anal, Colon, and Rectal Cancers; Head and Neck Cancer; Lung Cancer; Colon Cancer; Colonic Neoplasms; Colorectal Neoplasms; Colon/Rectal Cancer; Colon/Rectal Cancer Colon Cancer; Colon/Rectal Cancer Rectal Cancer; Colon/Rectal Cancer Anal Cancer; Head and Neck Cancers; Head and Neck Cancers Lip; Head and Neck Cancers Oral Cavity; Head and Neck Cancers Nasopharynx; Head and Neck Cancers Oropharynx; Head and Neck Cancers Hypopharynx; Head and Neck Cancers Larynx; Head and Neck Cancers Trachea; Lung Cancer Non-Small Cell Cancer (NSCLC); Lung Cancer Small Cell Lung Cancer (SCLC)
- 6RecruitingLast Updated: March 2, 2009Condition(s): Metastatic Malignancies
- 7Active, not recruitingLast Updated: April 6, 2011Condition(s): Solid Tumor
- 8CompletedLast Updated: December 13, 2009Condition(s): Dermatologic Complications; Unspecified Adult Solid Tumor, Protocol Specific
- 9RecruitingLast Updated: January 24, 2012Condition(s): Brain and Central Nervous System Tumors
- 10RecruitingLast Updated: February 24, 2012Condition(s): Non-Small Cell Lung Cancer; EGFR Tyrosine Kinase Inhibitor 324674
- 11RecruitingLast Updated: February 22, 2011Condition(s): Dermatologic Complications; Unspecified Adult Solid Tumor, Protocol Specific
- 12RecruitingLast Updated: October 18, 2010Condition(s): Cancer; Skin Rash
- 13RecruitingLast Updated: April 10, 2012Condition(s): Advanced Malignancies; Carcinoma, Non-Small-Cell Lung; Anaplastic Large Cell Lymphoma; Diffuse Large Cell Lymphoma; Inflammatory Myofibroblastic Tumors
- 14RecruitingLast Updated: January 3, 2012Condition(s): Cancer of the Head and Neck
- 15RecruitingLast Updated: May 5, 2011Condition(s): Medication Reaction
- 16TerminatedLast Updated: February 10, 2012Condition(s): Breast Cancer
- 17CompletedLast Updated: June 10, 2011Condition(s): Non-Small-Cell Lung Carcinoma
- 18Active, not recruitingLast Updated: October 18, 2011Condition(s): Lung Cancer
- 19CompletedLast Updated: May 27, 2011Condition(s): Non-small-cell Lung Carcinoma
- 20CompletedLast Updated: September 21, 2010Condition(s): Head and Neck Cancer
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=EGFR-tyrosine+kinase+inhibitor
